Quest Diagnostics
From Wikipedia, the free encyclopedia
Quest Diagnostics Incorporated (NYSE: DGX) is a United States corporation which provides clinical laboratory services . The company also has a business presence in England and Mexico.
Quest Diagnostics is a member of the Fortune 500 and the S&P 500. The company's corporate headquarters were previously located in Teterboro, New Jersey where the largest business unit is located. Currently, the corporate headquarters are located in Lyndhurst, New Jersey. Plans were announced in September 2006 that the corporate headquarters will be relocated to Madison, New Jersey in mid-2007.
Contents |
[edit] History
- 1967: Founded as MetPath, Inc., in New York.
- 1982: MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories.
- 1996: Quest Diagnostics becomes an independent company as a spin-off from Corning.
- 1999: Acquires SmithKline Beecham Clinical Laboratories; GlaxoSmithKline still holds a large portion of Quest Diagnostics stock.
- 2001: Completes acquisition of Ohio-based MedPlus, Inc. (NASDAQ: MEDP), a healthcare technology company.
- 2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc. (AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.
- 2003: Completes acquisition of California-based Unilab Corporation (NASDAQ: ULAB) in a transaction valued at approximately $800 million .
- 2005: Completes acquisition of Kansas-based LabOne, Inc. (NASDAQ: LABS) for $934 million in cash.
- 2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.
- 2007: Quest Diagnostics celebrates its 10th year after being spun off from Corning.
- 2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company, for approximately $420 million.
[edit] Key Facts
- The nation's leading provider of diagnostic testing, information and services, serving approximately 140 million patients each year.
- A workforce of approximately 39,000 dedicated employees, including more than 400 M.D's and Ph. D's.
- More than 33 regional laboratories in key U.S. markets, plus the UK, and Mexico.
- Two esoteric testing laboratories, one on each coast: San Juan Capistrano, CA and Chantilly, VA.
- 2,000 patient service centers.
- Revenues of $5.1 billion in 2004.
- Revenues of $6.3 billion in 2006.
- Leadership in gene-based and esoteric testing, with gene-based testing revenues of approximately $600 million annually.
- Leadership in substance abuse testing.
- First laboratory in the U.S. to achieve ISO 9001 certification.
[edit] Quest Diagnostics Logistics Department
This file is an original work. It is created for purpose of an inside view of the operation of one of the many departments within the structure of Quest Diagnostics. The details contained here represent only a small portion of the function of the Logistics Department. Logistics Department Quest Diagnostics
